Huakang Biomedical Holdings Co Ltd (hkse:08622) Share Price

Company Profile

Business description
Huakang Biomedical Holdings Co Ltd is engaged in the research, development, manufacture, marketing, and sale of in-vitro diagnostic reagents and auxiliary reproductive supplies and equipment in China. Its products include Male fertility IVD reagents; Parasite antibody detection reagents, EBV antibody detection reagents, and Auxiliary reproductive supplies and equipment. The group has also diversified its business to vitamins and supplements products for the markets in the PRC, Hong Kong, and Canada. The company derives maximum revenue from PRC.
Contact
No.16 Yinkui Road
1-3 floor and 5th floor, Building D, Shenzhen Junxuan
Kui Xin Community, Kui Chong Office
Dapeng New District
Shenzhen
CHN
T: +86 75533853878
https://www.szhuakang.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
90

Recommended

A year on from Guzman’s IPO, I catch up with Johannes Faul to explore what is baked into GYG’s valuation.

Joseph Taylor | 16 July 2025

Nvidia is poised to become more dominant than ever as it is allowed to sell its key H20 GPUs in China.

Brian Colello, CPA | 16 July 2025

These companies are our top choices for investors wanting to boost Aussie exposure.

Simonelle Mody | 15 July 2025

Index	Last price	Change	% Change
All Ordinaries	8,816.40	58.90	-0.66%
CAC 40	7,772.25	6.04	0.08%
DAX 40	24,177.48	117.19	0.49%
Dow JONES (US)	44,203.89	180.60	0.41%
FTSE 100	8,971.22	32.90	0.37%
HKSE	24,517.76	72.36	-0.29%
NASDAQ	20,699.44	21.64	0.10%
Nikkei 225	39,663.40	14.62	-0.04%
NZX 50 Index	12,754.59	64.96	0.51%
S&P 500	6,258.33	14.57	0.23%
S&P/ASX 200	8,561.80	68.50	-0.79%
SSE Composite Index	3,503.78	1.22	-0.03%